Prostate cancer pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{CMG}} {{Prostate cancer}} ==Overview== ==Pathophysiology== [[Image:Normal cancer cell division from NIH-2.png|thumb|left|When normal cells are damaged beyond repair, they ...")
 
Line 16: Line 16:


Prostate cancer is considered a [[malignant]] tumor because it is a mass of cells which can invade other parts of the body. This invasion of other organs is called [[metastasis]]. Prostate cancer most commonly metastasizes to the [[bone]]s, [[lymph node]]s, rectum, and bladder.
Prostate cancer is considered a [[malignant]] tumor because it is a mass of cells which can invade other parts of the body. This invasion of other organs is called [[metastasis]]. Prostate cancer most commonly metastasizes to the [[bone]]s, [[lymph node]]s, rectum, and bladder.
==Histopathological Findings in Prostatic Adenocarcinoma==
=== Prostate: Adenocarcinoma===
{{#ev:youtube|1SZPLS1dxTo}}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 19:04, 15 December 2011

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Prostate cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prostate Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Alternative Therapy

Case Studies

Case #1

Prostate cancer pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prostate cancer pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prostate cancer pathophysiology

CDC on Prostate cancer pathophysiology

Prostate cancer pathophysiology in the news

Blogs on Prostate cancer pathophysiology

Directions to Hospitals Treating Prostate cancer

Risk calculators and risk factors for Prostate cancer pathophysiology

Overview

Pathophysiology

When normal cells are damaged beyond repair, they are eliminated by apoptosis. Cancer cells avoid apoptosis and continue to multiply in an unregulated manner.

Prostate cancer is classified as an adenocarcinoma, or glandular cancer, that begins when normal semen-secreting prostate gland cells mutate into cancer cells. The region of prostate gland where the adenocarcinoma is most common is the peripheral zone.

Initially, small clumps of cancer cells remain confined to otherwise normal prostate glands, a condition known as carcinoma in situ or prostatic intraepithelial neoplasia (PIN).

Although there is no proof that PIN is a cancer precursor, it is closely associated with cancer. Over time these cancer cells begin to multiply and spread to the surrounding prostate tissue (the stroma) forming a tumor.

Eventually, the tumor may grow large enough to invade nearby organs such as the seminal vesicles or the rectum, or the tumor cells may develop the ability to travel in the bloodstream and lymphatic system.

Prostate cancer is considered a malignant tumor because it is a mass of cells which can invade other parts of the body. This invasion of other organs is called metastasis. Prostate cancer most commonly metastasizes to the bones, lymph nodes, rectum, and bladder.

Histopathological Findings in Prostatic Adenocarcinoma

Prostate: Adenocarcinoma

{{#ev:youtube|1SZPLS1dxTo}}

References